Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01277770
Other study ID # 00011652
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 2009
Est. completion date May 6, 2019

Study information

Verified date May 2019
Source University of Minnesota - Clinical and Translational Science Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to improve outcome for kidney transplant recipients. There has not been commensurate improvement in medium and long-term outcomes. Ongoing clinical research is necessary to improve transplant outcomes.


Description:

This study is looking at information already collected of transplant outcomes (short, medium and long-term complications and quality of life). This will specifically look at:

1. 10 year follow-up of steroid-free maintenance immunosuppression

2. A cross-sectional study of infection after kidney transplantation (with emphasis on infection in steroid-free recipients

3. An evaluation of the Delayed Graft Function (DGF) nomogram in Thymoglobulin treated recipients at the University of Minnesota


Recruitment information / eligibility

Status Completed
Enrollment 7500
Est. completion date May 6, 2019
Est. primary completion date May 6, 2019
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Kidney Transplant Recipient at the University of Minnesota

- Kidney Transplant Recipients on steroid-free maintenance immunosuppression

Exclusion Criteria:

- Non-kidney transplant patients at the University of Minnesota

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Steroid-Free Maintenance Immunosuppression
10 year follow-up of steroid-free maintenance immunosuppression
Other:
Infection After Kidney Transplantation
A cross-sectional study of infection after kidney transplantation (with emphasis on infection in steroid-free recipients).
Drug:
Evaluation of the DGF nomogram in Thymoglobulin
An evaluation of the DGF nomogram in Thymoglobulin treated recipients at the University of Minnesota

Locations

Country Name City State
United States University Of Minnesota Minneapolis Minnesota

Sponsors (2)

Lead Sponsor Collaborator
University of Minnesota - Clinical and Translational Science Institute Genentech, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Data Analysis All studies are analyses from the Transplant Outcomes Database. Recipients have signed consent to have medical information entered into the database for these analyses. The database contains information on short, medium and long-term results. 10 year followup
See also
  Status Clinical Trial Phase
Completed NCT01919099 - Study of the Complications Associated With Certain Stem Cell Transplants